Baker Brothers Advisors - TONIX PHARMACEUTICALS HLDG C ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q2 2018$3,113,000
+48.4%
699,5000.0%0.02%
+27.8%
Q1 2018$2,098,000
-13.1%
699,5000.0%0.02%
-14.3%
Q4 2017$2,413,000
-24.4%
699,5000.0%0.02%
-19.2%
Q3 2017$3,190,000
+44.2%
699,500
+36.9%
0.03%
+36.8%
Q2 2017$2,212,000
+5.4%
510,922
+13.7%
0.02%
+11.8%
Q1 2017$2,099,000449,5000.02%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q3 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 699,500$3,113,0000.02%
DRW Securities, LLC 20,000$89,0000.01%
SG Americas Securities, LLC 13,500$60,0000.00%
Winch Advisory Services, LLC 300$1,0000.00%
Renaissance Technologies 287,300$1,122,0000.00%
DIMENSIONAL FUND ADVISORS LP 54,850$244,0000.00%
BANK OF AMERICA CORP /DE/ 270$1,0000.00%
WELLS FARGO & COMPANY/MN 4,500$20,0000.00%
NORTHERN TRUST CORP 12,480$56,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 38,714$172,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders